Serologic Assay Validation and Proficiency Testing of HIL-214 in Adults

A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 6 Months Through 59 Months of Age.

NCT02914275 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immune Response of Candidate H1N1 Influenza Vaccine GSK2340274A Following Seasonal Influenza Vaccination in Adults

NCT01059617 ·Status: COMPLETED ·Phase: PHASE1

Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older

NCT00979602 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Efficacy and Safety of GC3110B in Healthy Adults

NCT02915809 ·Status: UNKNOWN ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Infants From 6 Months to 35 Months of Age

NCT03285997 ·Status: UNKNOWN ·Phase: PHASE3

Safety and Immunogenicity of Trivalent Subunit Influenza Vaccine Produced in Mammalian Cell Culture Using the Strain Composition 2007/2008

NCT00511914 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity of Flublok Quadrivalent vs IIV4 in Adults 18-49 Years of Age

NCT02290509 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity of H1N1 Vaccines in Adults Aged 18 Years and Older

NCT00985088 ·Status: COMPLETED ·Phase: PHASE2

Safety and Immunogenicity Study of Two Doses of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)

NCT00517517 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study of the Protective Effect of an Injectable Influenza Vaccine Against Influenza Illness in Adults Under 50 y.o.

NCT00216242 ·Status: UNKNOWN ·Phase: PHASE3

Fluarix/ FluLaval/ Fluarix Quadrivalent/ FluLaval Quadrivalent Vaccine Pregnancy Registry

NCT02148211 ·Status: COMPLETED

Safety and Immunogenicity Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)

NCT00349141 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

To Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC3102C' Administered Intramuscularly in Healthy Adults

NCT01750814 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity and Safety Study of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults

NCT00989287 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Adolescents

NCT00900588 ·Status: COMPLETED ·Phase: PHASE2

Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older

NCT00753272 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age

NCT00970177 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Elderly Healthy Subjects

NCT03657719 ·Status: COMPLETED ·Phase: PHASE2

Immunogenicity and Safety of an Adjuvanted Inactivated Subunit Influenza Vaccine to Those of a Non-adjuvanted Inactivated Subunit Influenza Vaccine, When Administered to Adults Affected by Chronic Diseases

NCT00519064 ·Status: COMPLETED ·Phase: PHASE3

Randomized, Double-blind, Placebo-controlled, Phase I Dose-escalation Study of Single Dose GHB01L1 in Healthy Volunteers

NCT00724997 ·Status: COMPLETED ·Phase: PHASE1

Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to <36 Months

NCT00996307 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Infectivity, Replication & Immunogenicity of Live nH1N1 Vaccine

NCT01023776 ·Status: COMPLETED ·Phase: PHASE4

Safety and Immune Response of One-Dose of Candidate H1N1 Influenza Vaccine GSK2340274A in Adults

NCT01008956 ·Status: WITHDRAWN ·Phase: PHASE2

A Study to Evaluate the Safety and Immunogenicity of an Inactivated Split-virion Influenza A(H1N1) Vaccine

NCT01201902 ·Status: COMPLETED ·Phase: PHASE3

H5 Adult - Chiron Study of Bird Flu Vaccine

NCT00280033 ·Status: COMPLETED ·Phase: PHASE1/PHASE2